Ajan Reginald
Chief Executive Officer at ROQUEFORT THERAPEUTICS PLC
Net worth: 642 517 $ as of 2024-04-29
Network origin in Ajan Reginald first degree
Entity | Entity type | Industry | |
---|---|---|---|
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom.
17
| Subsidiary | Biotechnology | 17 |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Celixir Plc discovers and develops regenerative medicines to treat life threatening and life altering diseases. It offers heartcel-immunomodulatory progenitor imp cells, tendoncel-platelet lysate based therapy, myocardion-progenitor cells of mesodermal lineage. The company was founded by Martin Evans and Ajan Reginald in 2009 and is headquartered in Stratford-upon-Avon, the United Kingdom.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Public Company | Pharmaceuticals: Major | 9 | |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Desktop Genetics Ltd. develops software tools to enable literal desktop genetics. It offers technologies at the intersection of biotechnology, software and laboratory automation. The firm specializes in synthetic biology, genome engineering, genome editing, functional genomics, bioinformatics, and screening. The company was founded by Victor Dillard, Riley Doyle and Edward Perello in 2012 and is headquartered in London, the United Kingdom.
1
| Subsidiary | Packaged Software | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ajan Reginald via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ONDINE BIOMEDICAL INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
BEACON ENERGY PLC | Oil & Gas Production | Director of Finance/CFO | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree | |
HARVARD INTERNATIONAL LTD | Electronics Distributors | Director/Board Member | |
Permira Advisers LLP
Permira Advisers LLP Investment ManagersFinance Permira Advisers LLP (Permira Advisers) is a private equity subsidiary of Permira Holdings Ltd founded in 1985 by Peter M. Smitham. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
University of Oxford | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
European Hydrocarbons Ltd.
European Hydrocarbons Ltd. Oil & Gas ProductionEnergy Minerals European Hydrocarbons Ltd. explores oil and gas properties. The company was founded in 1997 and is headquartered in London, UK | Oil & Gas Production | Director/Board Member | |
University of London | College/University | Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree | |
University College London | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
APOL CONS | Precious Metals | Director/Board Member | |
Swansea University | College/University | Corporate Officer/Principal | |
TOMCO ENERGY PLC | Oil & Gas Production | Chairman | |
The Royal College of Physicians | College/University | Graduate Degree | |
QS Pharma LLC
QS Pharma LLC Medical SpecialtiesHealth Technology QS Pharma LLC provides contract research services for pharmaceutical and biopharmaceutical companies. It offers NCE screening, identification, preformulation characterization, preclinical and toxicology, formulation development, clinical trial materials, potency manufacturing, analytical and commercial manufacture services. The company was founded in 2002 and is headquartered in Boothwyn, PA. | Medical Specialties | Director/Board Member | |
King's College London | College/University | Corporate Officer/Principal Undergraduate Degree | |
McKinsey & Co., Inc. (United Kingdom)
McKinsey & Co., Inc. (United Kingdom) Investment ManagersFinance Part of McKinsey & Co., Inc., McKinsey & Co., Inc. (United Kingdom) is a consulting firm that helps UK manufacturers embrace new technologies for digital transformation and leadership. The company is based in London, UK. Ruben Schaubroeck, McKinsey Digital's new lead for the UK, Belgium, and Netherlands offices, spoke with Thomas Farrar, a manager of communications in the firm's UK office, about the importance of speed and pace for CEOs in this new growth journey. The British company works with organizations that pursue sustainability, inclusion, and economic growth, all at the same time, to achieve strategic foresight and built-in agility in the face of the COVID-19 pandemic and the new trading relationship with the EU. | Investment Managers | Corporate Officer/Principal | |
Pharmaq Holding AS
Pharmaq Holding AS Financial ConglomeratesFinance Pharmaq Holding AS invests in shares, obligations, real properties, and other participations. The company was founded on February 22, 2013 and is headquartered in Overhalla, Norway. | Financial Conglomerates | Director/Board Member | |
PETRONOR E&P ASA | Oil & Gas Production | Director of Finance/CFO | |
Regal Liberia Ltd. | Director/Board Member | ||
Silk Road Oil & Gas Ltd. | Director/Board Member | ||
XiMo AG
XiMo AG Chemicals: SpecialtyProcess Industries XiMo AG develops catalysts for the metathesis of organic compounds. The firm catalyst development, process development and reactor design. The firm serves in the area of agrochemicals, flavors and fragrances, pharmaceuticals, polymers, oils and waxes and surface treatments sectors. The company was founded by Richard Schrock and Amir Hoveyda in 2010 and is headquartered in Lucerne, Switzerland. | Chemicals: Specialty | Founder | |
AXCA HEALPAR | Biotechnology | Director/Board Member | |
Harvard Business School | College/University | Corporate Officer/Principal | |
Incube Investments Pty Ltd. | Director/Board Member | ||
Cresthaven Investments Pty Ltd. | Director/Board Member | ||
SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member | |
Petronor E&P Services AS
Petronor E&P Services AS Oil & Gas ProductionEnergy Minerals Petronor E&P Services AS engages in exploration of oil and gas. The company was founded by Knut Søvold and Gerhard Ludvigsen and is headquartered in Oslo, Norway. | Oil & Gas Production | Director/Board Member | |
African Petroleum Corporation (Services) Ltd.
African Petroleum Corporation (Services) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of PetroNor E&P Ltd., African Petroleum Corporation (Services) Ltd. provides management services. The company is based in London, UK and was founded in 2009. | Miscellaneous Commercial Services | Director/Board Member | |
Orana Corporate LLP
Orana Corporate LLP Miscellaneous Commercial ServicesCommercial Services Orana Corporate LLP is a boutique corporate advisory and services practice that partners with high growth businesses to maximize their potential through effective advice and teamwork. The private company is based in London, UK and has subsidiaries in the United Kingdom. The British company's team consists primarily of chartered accountants and corporate finance professionals with extensive experience dealing with quoted and private companies operating in a variety of sectors and jurisdictions. | Miscellaneous Commercial Services | Director/Board Member | |
PetroNor E&P Services Ltd. | Director/Board Member | ||
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
Mfw Resources Ltd. | Director/Board Member | ||
Savant Resources Plc | Director/Board Member | ||
Oilion Energy Ltd. | Director/Board Member | ||
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Part of Roquefort Therapeutics Plc, Oncogeni Ltd. operates as a British biotechnology company. The company is based in Stratford-upon-Avon, UK. The company was founded in 2019 by Nobel Laureate, Martin John Evans, Trevor Ajan Reginald. Oncogeni was acquired by Roquefort Therapeutics Plc on September 16, 2022 for $4.61 million. | Biotechnology | Director/Board Member Founder Founder | |
The Institute of Chartered Accountants in Australia | Corporate Officer/Principal | ||
Quotient Sciences Ltd.
Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences Ltd. provides early stage drug development services. The firm offers formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industries. The company was founded in 1990 and is headquartered in Ruddington, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Norsve Resources Plc | Director/Board Member |
Statistics
International
United Kingdom | 31 |
United States | 10 |
Australia | 5 |
Norway | 3 |
Canada | 2 |
Sectoral
Consumer Services | 12 |
Health Technology | 9 |
Energy Minerals | 8 |
Finance | 5 |
Commercial Services | 3 |
Operational
Director/Board Member | 140 |
Chairman | 36 |
Corporate Officer/Principal | 30 |
Founder | 16 |
Corporate Secretary | 12 |
Most connected contacts
Insiders | |
---|---|
Stephen Paul West | 28 |
Chaim Hurvitz | 25 |
Jean Duvall | 22 |
Digby Jones | 21 |
Mark Freeman | 16 |
Mark Hughes | 12 |
Michael Stein | 12 |
Darrin Disley | 11 |
Gary Pisano | 11 |
Simon Sinclair | 11 |
Mubasher Ahmad Sheikh | 10 |
Conor Kehoe | 9 |
Daniel Janse | 9 |
Armand Keating | 8 |
Martin Evans | 6 |
- Stock Market
- Insiders
- Ajan Reginald
- Company connections